Case report: A novel third-generation anti-CD19/CD22 CAR T-cells combined with auto-HSCT for relapsed Burkitt lymphoma

Case report: A novel third-generation anti-CD19/CD22 CAR T-cells combined with auto-HSCT for relapsed Burkitt lymphoma

This study explores a novel therapeutic strategy for relapsed/refractory (R/R) Burkitt lymphoma (BL) by integrating autologous hematopoietic stem cell transplantation (ASCT) with tandem anti-CD19/CD22 chimeric antigen receptor (CAR) T cell therapy. A 20-year-old Asian male with refractory BL, whose...

Full description

Saved in:

Bibliographic Details
Main Authors:	Xiaodan Luo, Ao Chen, Le Qin, Robert Weinkove, Rong Zhao, Ting Ye, Sihui Chen, Jianli Tang, Jianbo Liu, Jiayu Huang, Boyun Shi, Danyun Yuan, Huo Tan, Dajiang Qin, Zhaoyang Tang, Peng Li, Runhui Zheng
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-12-01
Series:	Frontiers in Immunology
Subjects:	relapsed/refractory Burkitt lymphoma CAR T-cell therapy autologous hematopoietic stem cell transplantation CD19/CD22 dual target immunotherapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1497736/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The CD39/CD73/Adenosine and NAD/CD38/CD203a/CD73 Axis in Cutaneous T-Cell Lymphomas
by: Liyun Lin, et al.
Published: (2025-02-01)

Novel Loop-Structure-Based CD19/CD22 Dual-Target CAR-T Therapy for High-Risk Diffuse Large B-Cell Lymphoma Presenting with Hemophagocytic Lymphohistiocytosis: A Case Report
by: Ye Y, et al.
Published: (2025-07-01)

Association of CD24, CD27, and co-stimulatory molecules CD80 immunological marker expression on B-cells of human peripheral blood with development of celiac disease
by: Rahab Abd-Ali Al-Madany, et al.
Published: (2024-12-01)

ADA/CD26 axis increases intra-tumor PD-1+CD28+CD8+ T-cell fitness and affects NSCLC prognosis and response to ICB
by: Ornella Franzese, et al.
Published: (2024-12-01)

The Role of Soluble CD163 (sCD163) in Human Physiology and Pathophysiology
by: Andriana Plevriti, et al.
Published: (2024-10-01)

Association of Absolute Lymphocyte Count and Circulating CD4+ and CD8+ T-Cells with Positive Clinical Outcome in Survivors of Cancer: An Observational Study
by: Suresh Rao, et al.
Published: (2019-07-01)

Tandem CD19/CD22 CAR T-cells as potential therapy for children and young adults with high-risk r/r B-ALLResearch in context
by: Berta González-Martínez, et al.
Published: (2025-08-01)

Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial
by: Jerome Roncalli, et al.
Published: (2025-04-01)

CYTOTOXIC ACTIVITY OF DENDRITIC CELLS AGAINST ACTIVATED CD4+ AND CD8+T-LYMPHOCYTES IN THE CULTURE IN VITRO
by: T. V. Tyrinova, et al.
Published: (2012-05-01)

CD22 modulation alleviates amyloid β-induced neuroinflammation
by: Yu Dong Mai, et al.
Published: (2025-02-01)

CD4+T and CD8+T cells profile in lung inflammation and fibrosis: targets and potential therapeutic drugs
by: Xiaobo Sun, et al.
Published: (2025-05-01)

Two chemotherapeutic agents expand stem-like CD62L+CD8+ T cells in antitumor immune responses
by: Xiaokang Ruan, et al.
Published: (2025-04-01)

Co-stimulation of CD28/CD40 signaling molecule potentiates CAR-T cell efficacy and stemness
by: Wannakorn Khopanlert, et al.
Published: (2024-09-01)

Dual CD47 and PD‐L1 blockade elicits anti‐tumor immunity by intratumoral CD8+ T cells
by: Susan N Christo, et al.
Published: (2024-01-01)

A high proportion of CD38 (high) CD16 (low) NK cells in colorectal cancer can interrupt immune surveillance and favor tumor growth
by: Xueling Wang, et al.
Published: (2025-07-01)

Therapeutic Efficacy of CD34-Derived Allogeneic Dendritic Cells Engineered to Express CD93, CD40L, and CXCL13 in Humanized Mouse Models of Pancreatic Cancer
by: Sara Huerta-Yepez, et al.
Published: (2025-07-01)

CD161+CD127+CD8+ T cell subsets can predict the efficacy of anti-PD-1 immunotherapy in non-small cell lung cancer with diabetes mellitus
by: Jingjing Qu, et al.
Published: (2024-12-01)

The unreversible reduced but persistent activated NK and CD8+ T cells in severe/critical COVID-19 during omicron pandemic in China
by: Ling Qin, et al.
Published: (2023-12-01)

Itolizumab regulates activating and inhibitory signals on effector cells, improving their cytotoxicity against CD318+ tumor cell lines
by: Cynthia González Muñoz, et al.
Published: (2025-05-01)

CD39+ conventional CD4+ T cells with exhaustion traits and cytotoxic potential infiltrate tumors and expand upon CTLA-4 blockade
by: Sabrina N. Bossio, et al.
Published: (2023-12-01)

The significance of CD4+ and CD8+ T lymphocyte infiltration in esophageal squamous cell carcinoma
by: Jiang Y. Zhao, et al.
Published: (2025-01-01)

EXPRESSION OF CD-31/CD-34 IN PATIENTS WITH І-ІІ STAGES NON-SMALL CELL LUNG CANCER
by: O. P. Kolesnik, et al.
Published: (2013-12-01)

The combined effects of swimming exercise and stem cell transplantation on the expression of CD9 and CD63 tetraspanin genes in a rat model of azoospermia
by: Maziyar Shojaee, et al.
Published: (2024-10-01)

An elevated percentage of CD4⁺CD25⁺CD127low regulatory T cells in peripheral blood indicates a poorer prognosis in hepatocellular carcinoma after curative hepatectomy
by: Haoran Sun, et al.
Published: (2025-05-01)

CD36 promotes iron accumulation and dysfunction in CD8 T cells via the p38-CEBPB-TfR1 axis in earlystage hepatocellular carcinoma
by: Yifei Qin, et al.
Published: (2025-07-01)

Very late relapse of Burkitt's lymphoma in an EBV-negative patient after 20 years of complete remission
by: Kmar Mrad, et al.
Published: (2024-01-01)

Coexpression of CD5 and CD43 predicts worse prognosis in diffuse large B‐cell lymphoma
by: Xiao‐bo Ma, et al.
Published: (2018-09-01)

CD73+CD8+ T cells define a subset with anti-tumor potential in DLBCL patients
by: Lingyu Zhang, et al.
Published: (2025-05-01)

Intrahepatic CD161hiCD8+T Cell Recruitment Has a Pathogenetic Potential in Chronic HBV Infection
by: Jianfei Li, et al.
Published: (2025-01-01)

Immune profiling identifies CD161+CD127+CD8+ T cells as a predictive biomarker for Anti-PD-L1 therapy response in the SCLC-I subtype
by: Jingjing Qu, et al.
Published: (2025-07-01)

sCD40 and sCD40L as candidate biomarkers of rheumatic diseases: a systematic review and meta-analysis with meta-regression
by: Angelo Zinellu, et al.
Published: (2025-03-01)

CD22 blockade exacerbates neuroinflammation in Neuromyelitis optica spectrum disorder
by: Wenjun Zhang, et al.
Published: (2024-11-01)

FEATURES OF EXPRESSION OF CD133 AND CD44 MARKERS OF TUMOR STEM CELLS WITH METASTATIC AND NON-METASTATIC GASTRIC CANCER
by: A. B. Sagakyants, et al.
Published: (2021-03-01)

Expression of CD55, CD59, and CD35 on red blood cells of β-thalassaemia patients
by: Ayşegül Uğur Kurtoğllu, et al.
Published: (2017-05-01)

Isochronal Studies of the Structural and Electrical Properties of CdTe Films
by: Baghdad Science Journal
Published: (2011-03-01)

Elevated CD14 in B cells associates with reduced ovarian cancer risk via CD80 + dendritic cell interaction: a multi-omics study
by: Mengyu Zheng
Published: (2025-06-01)

Subpopulations of mobilized hematopoietic stem cells in patients with hematological malignances and donors: expression of CD38, HLA-DR and CD143
by: M. L. Kanaeva, et al.
Published: (2019-07-01)

Soluble CD127 potentiates IL‐7 activity in vivo in healthy mice
by: Nawaf A. Aloufi, et al.
Published: (2021-12-01)

Global research trends in the relationship between influenza and CD4+ T/CD8+ T cells: A bibliometric analysis
by: Yanping Zong, et al.
Published: (2024-12-01)

Correlation of CD34+ Hematopoietic Stem Cells and CFU in Peripheral Blood Apheresis Products in Patients with Malignant Lymphoproliferative Diseases Before and After Cryopreservation Prior to auto-HSCT
by: VA Balashova, et al.
Published: (2018-10-01)